| 000 | 01568 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513150730.0 | ||
| 264 | 0 | _c19981028 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0049-3848 | ||
| 024 | 7 |
_a10.1016/s0049-3848(98)00037-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPawlak, D | |
| 245 | 0 | 0 |
_aA potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats. _h[electronic resource] |
| 260 |
_bThrombosis research _cJun 1998 |
||
| 300 |
_a259-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAorta, Abdominal |
| 650 | 0 | 4 | _aBleeding Time |
| 650 | 0 | 4 |
_aKetanserin _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aReceptor, Serotonin, 5-HT2A |
| 650 | 0 | 4 |
_aReceptors, Serotonin _xdrug effects |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aThrombophlebitis _xprevention & control |
| 650 | 0 | 4 |
_aThrombosis _xprevention & control |
| 650 | 0 | 4 |
_aTriazines _xpharmacology |
| 700 | 1 | _aPawlak, K | |
| 700 | 1 | _aChabielska, E | |
| 700 | 1 | _aMałyszko, J | |
| 700 | 1 | _aTakada, A | |
| 700 | 1 | _aMyśliwiec, M | |
| 700 | 1 | _aBuczko, W | |
| 773 | 0 |
_tThrombosis research _gvol. 90 _gno. 6 _gp. 259-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0049-3848(98)00037-1 _zAvailable from publisher's website |
| 999 |
_c9666481 _d9666481 |
||